These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9295091)

  • 21. Disclosing the diagnosis of HIV in pediatrics.
    Flanagan-Klygis E; Ross LF; Lantos J; Frader J; Yogev R
    J Clin Ethics; 2001; 12(2):150-7. PubMed ID: 11642067
    [No Abstract]   [Full Text] [Related]  

  • 22. My toughest choice.
    Kane L
    Med Econ; 2002 Oct; 79(19):122, 125, 129. PubMed ID: 12407815
    [No Abstract]   [Full Text] [Related]  

  • 23. [First-trimester screening for Down syndrome: recommendations for what purpose?].
    Senat MV
    Gynecol Obstet Fertil; 2007 Oct; 35(10):1069-70. PubMed ID: 17897867
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple marker screening for Down syndrome in the first trimester of pregnancy.
    Wallace EM
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):368-70. PubMed ID: 9325534
    [No Abstract]   [Full Text] [Related]  

  • 25. Dual analyte screening for fetal Down syndrome in pregnant women over 35 years of age.
    Cavalli P; Gnocchi E; Pennacchio A; Morrica B
    Prenat Diagn; 1998 Jun; 18(6):637-8. PubMed ID: 9664616
    [No Abstract]   [Full Text] [Related]  

  • 26. Christmas 1962: a year of firsts.
    Hawke M
    Nurs Spectr (Wash D C); 1998 Dec; 8(25):24. PubMed ID: 10542677
    [No Abstract]   [Full Text] [Related]  

  • 27. How would you handle these ethical dilemmas?
    Finger AL
    Med Econ; 1997 Oct; 74(21):105-6, 108, 113-7. PubMed ID: 10174066
    [No Abstract]   [Full Text] [Related]  

  • 28. Arrival. Down syndrome.
    Estreich G
    Ambul Pediatr; 2008; 8(6):351-3. PubMed ID: 19084783
    [No Abstract]   [Full Text] [Related]  

  • 29. A surgeon's response to the intersex controversy.
    Schober JM
    J Clin Ethics; 1998; 9(4):393-7. PubMed ID: 10029840
    [No Abstract]   [Full Text] [Related]  

  • 30. Denying treatment to Down's syndrome children.
    Keenan P; McIntosh P
    Prof Care Mother Child; 1999; 9(5):133. PubMed ID: 10818954
    [No Abstract]   [Full Text] [Related]  

  • 31. Recurrences of free trisomy 21: analysis of data from the National Down Syndrome Cytogenetic Register.
    Morris JK; Mutton DE; Alberman E
    Prenat Diagn; 2005 Dec; 25(12):1120-8. PubMed ID: 16231400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Maternal serum screening for Down's syndrome].
    Muller F
    Ann Biol Clin (Paris); 2002; 60(6):689-92. PubMed ID: 12446233
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening for Down's syndrome. Serum screening shows a clear benefit across age groups.
    McCune GS; Stock AS; Foakes A
    BMJ; 2000 Sep; 321(7263):762-3; author reply 764-5. PubMed ID: 10999924
    [No Abstract]   [Full Text] [Related]  

  • 34. How should careproviders respond when the medical system leaves a patient short?
    Howe EG
    J Clin Ethics; 2007; 18(3):195-205. PubMed ID: 18051936
    [No Abstract]   [Full Text] [Related]  

  • 35. Prenatal screening for Down syndrome.
    Ogle RF; Chitty LS
    Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing for Down syndrome in the older woman: a risky business?
    Hodges RJ; Wallace EM
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):486-8. PubMed ID: 16401213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum screening for anomalies in pregnancy: reasons for acceptance or refusal of the test.
    Gokhale LS; Cietak KA
    J Obstet Gynaecol; 2002 Jul; 22(4):392-3. PubMed ID: 12521462
    [No Abstract]   [Full Text] [Related]  

  • 38. Acceptance of screening and abortion for Down syndrome among Finnish midwives and public health nurses.
    Jallinoja P; Santalahti P; Toiviainen H; Hemminki E
    Prenat Diagn; 1999 Nov; 19(11):1015-22. PubMed ID: 10589051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient preference regarding first-trimester aneuploidy risk assessment.
    Sharma G; Gold HT; Chervenak FA; McCullough L; Alt AK; Chasen ST
    Am J Obstet Gynecol; 2005 Oct; 193(4):1429-36. PubMed ID: 16202737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prenatal diagnosis of Down's syndrome: prediction from maternal serum markers].
    Zilberstein T; Maymon E
    Harefuah; 1998 Mar; 134(5):393-6. PubMed ID: 10909560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.